16. Type II diabetes mellitus Flashcards

1
Q

What happens to ketones in the body in T2D?

A
  • Abnormal ketones in blood or urine if glucose is high

* Ketosis not seen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the values for fasting glucose, 2 hour glucose and glucose at any time in diabetes mellitus?

A
  • Fasting glucose > 7 mmol/l
  • 2 hour glucose > 11 mmol/l
  • Any time > 11 mmol/l
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does a fasting glucose level between 6 and 7, and a 2 hour glucose between 7.8 and 11.1 show?

A
  • Impaired fasting glucose (fasting glucose)
  • Impaired glucose tolerance (2 hour glucose)
  • Increased macrovascular risk
  • Diabetes risk
  • Not a microvascular risk (only with diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the pathophysiology of T2D

A
  • Genetic condition - genes, intrauterine environment and adult environment have a role
  • Practically all patients are insulin resistant
  • Patients also have an insulin secretion defect
  • Fatty acids are important in the pathogenesis and lead to complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is maturity onset diabetes of the young (MODY)?

A
  • Genetic disease (autosomal dominant) - all patients have a positive family history, and no obesity
  • Several hereditary forms (8)
  • Ineffective pancreatic insulin production
  • Mutations have been found in transcription factor genes for insulin, and the glucokinase gene
  • Specific treatments for the different types
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When does T2D start to affect a patient?

A

• Defective genes contribute to insulin resistance throughout an adult’s life (and probably childhood)
• Patient already need more insulin, 30 years before being hyperglycaemic
- mechanisms brought about by adipocytokines (hormones made by fat cells)
- these hormones are a mechanism of the diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the genes for T2D associated with?

A

• Being born light (epigenetic effect is not known)
• Obesity and handling of fatty acids
- obesity is not just a precipitant of diabetes, but part of the mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is dyslipidaemia and what does it involve?

A
  • Abnormal amount of lipids in the blood
  • Involves abnormal handling of cholesterol
  • Along with the other effects of insulin resistance (mitogenic), this leads to macrovascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are identical or non-identical twins more likely to suffer from diabetes?

A

Identical twins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

As people become older, they become more insulin resistant, so why do most normal people not have problems with hepatic glucose output and muscle glucose uptake?

A
  • Able to produce more insulin to overcome this

* Individuals with diabetes can’t do this, as they become insulin deficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are products from the breakdown of triglycerides in adipocytes used for?

A
  • Triglycerides break down to release glycerol and non-esterified fatty acids
  • Fatty-acids contribute to the very low density lipoprotein triglyceride production
  • Glycerol contributes to glucose production (but this glucose is unfortunately not taken up in diabetes along with unsuppressed HGO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What percentage of T2D patients are obese at presentation?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are perturbations in gut microbiota associated with (with reference to diabetes)?

A
  • Obesity and insulin resistant T2D
  • Host signalling
  • Fermentation of bacterial lipopolysaccharides to short chain FA
  • Bacterial modulation of bile acids
  • Inflammation, signalling metabolic pathways

(most studies are correlative but the mechanisms aren’t confirmed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why could the intra-uterine environment be significant in diabetes?

A
  • Involved in programming insulin resistance for line
  • So far, genes associated with diabetes are involved with insulin secretion
  • Microbiota also comes from out mother, which may alter and express defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the T2D presentations?

A

• Osmotic symptoms
- decreased glucose reabsorption
- glucose leaks out of the urine, taking water with it (polyuria, polydipsia)
• Infections
- yeast and microorganisms thrive in high glucose environments
• Acute: hyperosmolar coma
• Chronic: ischaemic heart disease, retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the complications of T2D?

A
  • Microvascular - retinopathy, nephropathy, neuropathy
  • Macrovascular - ischaemic heart disease, cerebrovascular disease, renal artery stenosis, PVD
  • Metabolic - lactic acidosis, hyperosmolar complications
17
Q

What medication can be used to treat T2D?

A

• Weight - orlistat (GI lipase inhibitor)
• Glycaemia
- metformin and insulin
- sulphonylureas and metaglinides
- alpha-glucosidase inhibitors
- thiazolidinediones (act on central adiposity)
- GLP-1, and DPP4 inhibitors (prolong GLP-1 action) - newer agents
- SGLT2 inhibitors - increases glycosuria
• Blood pressure treatment
• Dyslipidaemia treatment

18
Q

What invasive procedure can be used in the treatment of T2D?

A
  • Gastric bypass

* However trials showed that adverse effects and nutritional deficiency increased

19
Q

What is metformin and how does it work?

A
  • Biguanide, acts as an insulin sensitiser
  • Given to overweight patients with T2D, where diet alone has not succeeded
  • Reduces insulin resistance - reduces HGO and increases peripheral glucose disposal
  • GI side effects, but it is very safe and effective
  • Do not use if suffering from severe liver, severe cardiac or mild renal failure
20
Q

What is a sulphonylurea and how does it work?

A
  • Glibenclamide, an insulin secretagogue
  • Given to lean patients with T2D

• When glucose enters the cell:
- it is metabolised with glucokinase acting as a glucose sensor
- ATP-sensitive K channel are blocked
- Ca2+ influx inducing insulin vesicle movement + release
• Sulphonylureas can bypass this and block the channel
• This induces insulin release

• Side effects - hypoglycaemia and weight gain

21
Q

What is acarbose and how does it work?

A
  • Alpha glucosidase inhibitor
  • Acts within the gut to prolong glucose and oligosaccharide absorption
  • Allows insulin secretion to cope, following defective first phase insulin
  • As effective as metformin
  • Side effects - flatus (gas)
22
Q

What is the incretin effect?

A

Food stimulates more insulin secretion if given orally rather than IV

23
Q

What does GLP-1 do?

A
  • Secreted in response to nutrients in the gut
  • Stimulates insulin and suppresses glucagon
  • Decreases [glucose]
  • Transcription product of the pro-glucagon gene, mostly from L cells
  • Increases satiety
  • Restores B cell glucose sensitivity
  • Short half-life, rapid degradation from enzyme dipeptidyl peptidase-4
24
Q

How can we manipulate the effects of GLP-1 clinically?

A
• GLP-1 agonists: exenatide, liraglutide
- injectable, long acting GLP-1 agonist
• Gliptins: DPPG-4 inhibitors
- oral agents
- increases half-life of GLP-1, increasing [GLP-1]
25
Q

Is there a HLA association in T2D?

A

No

26
Q

Describe the presence of islet cell antibodies in T2D

A

There are none